SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark A. Stang who wrote (11048)7/9/1998 9:54:00 PM
From: VLAD  Read Replies (2) of 23519
 
Mark,

A few points:

Inventory Q1 was 11.7 million not 9 million.

In the cc the CFO said that the increase in inventories was primarily due to increased international finished goods and aloprostidal raw materials.

Inventory amounts include raw materials and finished goods. Vivus sold 2,200,000 more units in Q2 than in Q1.

I think they will have more material on hand as the international demand will require more product. The shelf life for MUSE is 18 months.

Wilson also said that based on wholesaler orders late in June and early this month, domestic demand looks as it will be rising in the very near future.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News